Logo Image
|Articles|October 2, 2022

Pharmaceutical Technology

  • Pharmaceutical Technology, October 2022
  • Volume 46
  • Issue 10
  • Pages: 12

Inorganic DNA Replication Enzyme

The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.

Canvax’s new inorganic pyrophosphatase is a DNA replication enhancer with ≥ 95% purity and has an enhanced capacity for increasing RNA yield in in-vitro transcription (IVT) reactions. The enzyme, which is isolated from Escherichia coli, has demonstrated stability below 80ºF, and is free of endonucleases, exonucleases, and RNAases.

The enzyme is intended for use in RNA IVT reactions, as it is designed to reduce the inhibitory effects of protein-protein interactions. In addition, it is suitable for use in messenger RNA-based vaccine manufacturing, RNA labeling, and enhancement of DNA replication.

Canvax

Articles in this issue

almost 4 years ago

Adopting Smart Development Strategies

almost 4 years ago

Application of F Charts in Continued Process Verification of OSD Forms

almost 4 years ago

Reformulating Success

almost 4 years ago

Analyzing Extractables and Leachables in Single-Use Systems

almost 4 years ago

Improving Sterility Using Blow-Fill-Seal Technology

almost 4 years ago

Electrochemistry for API Synthesis

almost 4 years ago

Shining a Light on Lipid Nanoparticle Characterization

almost 4 years ago

The Future of Drug Delivery for Biopharmaceuticals

almost 4 years ago

The State of Contamination Control

almost 4 years ago

Biologic Standards in the Pharmacopoeias: An Update

Related Content